Patient Access to ESRD New Innovative Devices Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Patient Access to ESRD New Innovative Devices Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2025: Patient Access to ESRD New Innovative Devices Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-2025/
"S. 2025: Patient Access to ESRD New Innovative Devices Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2025/.
S. 2025, 117th Cong. (2026), https://openamerica.io/bill/117-S-2025/.
[S. 2025: Patient Access to ESRD New Innovative Devices Act](https://openamerica.io/bill/117-S-2025/)